Ardelyx (ARDX) Free Cash Flow Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 31.42% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | 10.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.33% |
| Dec 31, 2025 | 13.11% |
| Sep 30, 2025 | 26.16% |
| Jun 30, 2025 | 5.99% |
| Mar 31, 2025 | -11.98% |
| Dec 31, 2024 | 30.73% |
| Sep 30, 2024 | 26.21% |
| Jun 30, 2024 | 17.69% |
| Mar 31, 2024 | 7.27% |
| Dec 31, 2023 | 21.10% |
| Sep 30, 2023 | -2.82% |
| Jun 30, 2023 | 7.96% |
| Mar 31, 2023 | -21.52% |
| Dec 31, 2022 | 48.54% |
| Sep 30, 2022 | -7.05% |
| Jun 30, 2022 | -3.93% |
| Mar 31, 2022 | -17.38% |
| Dec 31, 2021 | -28.12% |
| Sep 30, 2021 | -9.09% |
| Jun 30, 2021 | -24.80% |
| Mar 31, 2021 | -87.20% |
| Dec 31, 2020 | -79.88% |
| Sep 30, 2020 | -0.45% |
| Jun 30, 2020 | 8.31% |
| Mar 31, 2020 | 3.61% |
| Dec 31, 2019 | 27.73% |
| Sep 30, 2019 | 7.57% |
| Jun 30, 2019 | -3.41% |
| Mar 31, 2019 | -1.26% |
| Dec 31, 2018 | 5.32% |
| Sep 30, 2018 | -22.53% |
| Jun 30, 2018 | 15.75% |
| Mar 31, 2018 | 6.69% |
| Dec 31, 2017 | 43.71% |
| Sep 30, 2017 | -50.45% |
| Jun 30, 2017 | -45.13% |
| Mar 31, 2017 | -184.24% |
| Dec 31, 2016 | -66.77% |
| Sep 30, 2016 | -392.31% |